News for hackers. Stuff that matters.

A comment on Pfizer and BioNTech Conclude Phase 3 Study of Covid-19 Vaccine Candidate. Parent comment

Re:Pfizer and BioNTech Conclude Phase 3 Study of Covid-19 Va... by maxerickson on Wednesday November 18, 2020 @09:51AM (#25137356)
They are going to charge the US ~$40. So $800,000 to prevent 150 cases. That's incredibly cheap, and doesn't factor in an increase of social activities.
[ Parent | on HN ]
Re:Pfizer and BioNTech Conclude Phase 3 Study of Covid-19 Va... by trebligdivad on Wednesday November 18, 2020 @10:08AM (#25137552)
if it's targeted at the elderly/at risk (at first?), the reduction in hospitalisation should be higher; and I'd think that would pay back pretty quickly.
[ Parent | on HN ]
Re:Pfizer and BioNTech Conclude Phase 3 Study of Covid-19 Va... by maxerickson on Wednesday November 18, 2020 @11:50AM (#25139017)
Yes, it's likely a net reduction in spending, and then on top of that a bunch of harm and death is prevented. Super cheap.
[ Parent | on HN ]